Sonoma Pharmaceuticals   Report issue

For profit Phase 2 Phase 4
Founded: Petaluma CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2007
NCT00516958
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Oculus Innovative Sciences | Oculus Innovative Sciences, Inc.

Active Ingredients

Drugs in Phase 4 Trials (3)

hypochlorous acid (1 trial)

sodium chloride (1 trial)

sodium magnesium fluorosilicate (1 trial)

Drugs in Phase 2 Trials (2)

dermacyn (1 trial)

levofloxacin (levaquin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Infections (Phase 2)

Pressure Ulcer (Phase 4)

Spinal Cord Injuries (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5